Search clinical trials for: Fedovapagon
Total 4 results
-
Vantia LtdCompleted
-
Vantia LtdCompleted
-
Vantia LtdCompleted
-
Vantia LtdCompleted
Sponsors and Collaborators
- Biotics, Inc.
- Plymouth University Peninsula Schools of Medicine & Dentistry (PUPSMD)
- Fabian Rohner
- José Castro
- Bon Secours Pediatric Dental Associates
- Belfast Arthroplasty Research Trust (BART)
- Universität Tübingen
- Junta de Andalucía - Consejería de Salud y Familias, Spain
- Narhalsan primary care rehabilitation
- Castleton University
- Shanghai IxCell Biotechnology Co., LTD
- Crowley Carter Foundation
- Mexican Emerging Infectious Diseases Clinical Research Network
- University of Valladolid
- Hospital Sirio-Libanes Ensino e Pesquina
- Don Cockcroft
- Damagen Genetic Diagnostic Center
- GTEI
- MB Clinical Research, LLC
- Department of Cardiology, Lausanne University Center Hospital, Lausanne, Switzerland
- View Full List
Medical Conditions
- Refractory Childhood Epilepsy
- Syndrome Heart Disease
- PSA Level Greater Than or Equal to 0.5
- Vascular Aging
- Stage V Wilms Tumor
- Chronic Arthritis, Longer Than Six Weeks Duration
- Lenses
- Infarction, Myocardial
- Residual Curarization
- Health Services, Geriatric
- Cystic Fibrosis in Adults, Chronic Colonization With Pseudomonas Aeruginosa
- Nasotracheal Intubation
- Milk Expression, Breast
- Gallbladder and Bile Duct Calculi
- Adolescent Oncology Patients
- Cryptococcosis or Aspergillosis Infections
- Vesicoureteral Reflux (VUR)
- Support Groups
- Lung Cancer Non Small Cell
- Congenital Nephrogenic Diabetes Insipidus
- View Full List
Drug Interventions
- ABT-199
- Metoprolol succinate sustained-release tablet
- SNAC
- Fluorouracil
- Lidocaine, epinephrine (Local anesthetic)
- Sulfasalazine
- Azacitidine
- Cabozantinib
- Gliadel Wafer
- Granulocyte colony-stimulating factor (G-CSF)
- PEP005 Gel
- Axitinib plus toripalimab
- Quadratus Lumborum Block type 2
- PF-05212384
- Etanercept
- Doxorubicin, L-asparaginase, PEG-L-asparaginase, Erwinia asparaginase
- Dapagliflozin
- ATG-010 60 mg, orally, twice weekly, each 4 week (28-day) a cycle
- Fluorescein + ALA
- Trimetazidine 35 mg
- View Full List
CROs by country
- Contract Research Organizations in Albania
- Contract Research Organizations in Bahamas
- Contract Research Organizations in Bahrain
- Contract Research Organizations in Equatorial Guinea
- Contract Research Organizations in Greece
- Contract Research Organizations in Hungary
- Contract Research Organizations in Japan
- Contract Research Organizations in Lebanon
- Contract Research Organizations in Mozambique
- Contract Research Organizations in Nigeria
- Contract Research Organizations in Pakistan
- Contract Research Organizations in Trinidad & Tobago
- Contract Research Organizations in Zimbabwe
- CRO list by country